Subscribe to RSS
Cognitive Deficits in Patients with COVID-19 Infection during Their Hospital Stay: An Exploratory StudyFunding None.
Background The literature on presence of cognitive deficits in patients recovered from coronavirus disease 2019 (COVID-19) infection is emerging. However, the data on whether cognitive deficits have its onset during the acute phase of illness has not been evaluated extensively.
Aim This article estimates the level of cognitive functioning of patients with COVID-19 while they were admitted to COVID-designated wards. Secondary objectives were to assess the influence of medical comorbidities, severity of COVID-19 infection, and depressive and anxiety symptoms on cognitive functioning in patients with COVID-19 infection.
Methods Sixty-six clinically stable patients with COVID-19 infection were evaluated during their inpatient stay on Hindi Montreal Cognitive Assessment scale (H-MoCA), Hindi Mini-Mental State Examination (HMSE) scale, Patient Health Questionnaire-9, and Generalized Anxiety Disorder Questionnaire -7.
Results The mean age of the study participants was 39.85 (standard deviation [SD] 16.89) years and the participants were evaluated after 9.34 (SD 4.98; median 9.0) days of being diagnosed with COVID-19 infection. About one-fourth (28.8%; n = 19) of the participants had cognitive impairment on HMSE and about two-fifths (n = 26; 39.39%) had cognitive impairment as per the cutoff used for H-MoCA. A higher level of cognitive deficits were seen among participants who were older, diagnosed with diabetes mellitus, and those who required oxygen support during their hospital stay prior to assessment.
Conclusion Low cognitive score was found in one-fourth (28.8%) to two-fifths (39.9%) of the persons, depending on the assessment scale among those with acute COVID-19 infection. Low cognitive score was more prevalent among the elderly, those with diabetes mellitus, and those who required oxygen support prior to the assessment.
Article published online:
09 March 2022
© 2022. Association for Helping Neurosurgical Sick People. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
- 1 Liu J-M, Tan B-H, Wu S, Gui Y, Suo J-L, Li Y-C. Evidence of central nervous system infection and neuroinvasive routes, as well as neurological involvement, in the lethality of SARS-CoV-2 infection. J Med Virol 2021; 93 (03) 1304-1313
- 2 Reza-Zaldívar EE, Hernández-Sapiéns MA, Minjarez B. et al. Infection mechanism of SARS-COV-2 and its implication on the nervous system. Front Immunol 2021; 11: 621735
- 3 Sheng B, Cheng SK, Lau KK, Li HL, Chan EL. The effects of disease severity, use of corticosteroids and social factors on neuropsychiatric complaints in severe acute respiratory syndrome (SARS) patients at acute and convalescent phases. Eur Psychiatry 2005; 20 (03) 236-242
- 4 Bohmwald K, Gálvez NMS, Ríos M, Kalergis AM. Neurologic alterations due to respiratory virus infections. Front Cell Neurosci. 2018 12. 386
- 5 Fugate JE, Lam EM, Rabinstein AA, Wijdicks EFM. Acute hemorrhagic leukoencephalitis and hypoxic brain injury associated with H1N1 influenza. Arch Neurol 2010; 67 (06) 756-758
- 6 Mao L, Jin H, Wang M. et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020; 77 (06) 683-690
- 7 Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry 2021; 8 (05) 416-427
- 8 Helms J, Kremer S, Merdji H. et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 2020; 382 (23) 2268-2270
- 9 Al-Sofiani ME, Albunyan S, Alguwaihes AM, Kalyani RR, Golden SH, Alfadda A. Determinants of mental health outcomes among people with and without diabetes during the COVID-19 outbreak in the Arab Gulf Region. J Diabetes 2021; 13 (04) 339-352
- 10 Almeria M, Cejudo JC, Sotoca J, Deus J, Krupinski J. Cognitive profile following COVID-19 infection: Clinical predictors leading to neuropsychological impairment. Brain Behav Immun Health. 2020 9. 100163
- 11 Jaywant A, Vanderlind WM, Alexopoulos GS, Fridman CB, Perlis RH, Gunning FM. Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19. Neuropsychopharmacology 2021; 46 (13) 2235-2240
- 12 Zhou H, Lu S, Chen J. et al. The landscape of cognitive function in recovered COVID-19 patients. J Psychiatr Res 2020; 129: 98-102
- 13 Woo MS, Malsy J, Pöttgen J. et al. Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Commun. 2020; 2 (02) fcaa205
- 14 Grover S, Sahoo S, Mehra A. et al. New consultation liaison model of providing care to COVID patients. Asian J Psychiatr 2020; 54: 102437
- 15 Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006; 166 (10) 1092-1097
- 16 Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16 (09) 606-613
- 17 Gupta M, Gupta V, Nagar Buckshee R, Sharma V. Validity and reliability of Hindi translated version of Montreal cognitive assessment in older adults. Asian J Psychiatr 2019; 45: 125-128
- 18 Nasreddine ZS, Phillips NA, Bédirian V. et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53 (04) 695-699
- 19 Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12 (03) 189-198
- 20 Tsolaki M, Iakovidou V, Navrozidou H, Aminta M, Pantazi T, Kazis A. Hindi Mental State Examination (HMSE) as a screening test for illiterate demented patients. Int J Geriatr Psychiatry 2000; 15 (07) 662-664
- 21 Soni SL, Kajal K, Yaddanapudi LN. et al. Demographic & clinical profile of patients with COVID-19 at a tertiary care hospital in North India. Indian J Med Res 2020; DOI: 10.4103/ijmr.IJMR_2311_20.
- 22 Kayina CA, Haritha D, Soni L. et al. Epidemiological & clinical characteristics & early outcome of COVID-19 patients in a tertiary care teaching hospital in India: a preliminary analysis. Indian J Med Res 2020; 152 (1 & 2): 100-104
- 23 Mohan A, Tiwari P, Bhatnagar S. et al. Clinico-demographic profile & hospital outcomes of COVID-19 patients admitted at a tertiary care centre in north India. Indian J Med Res 2020; 152 (1 & 2): 61-69
- 24 Argenziano MG, Bruce SL, Slater CL. et al. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series. BMJ 2020; 369: m1996
- 25 Suleyman G, Fadel RA, Malette KM. et al. Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in Metropolitan Detroit. JAMA Netw Open 2020; 3 (06) e2012270
- 26 Ciesielska N, Sokołowski R, Mazur E, Podhorecka M, Polak-Szabela A, Kędziora-Kornatowska K. Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis. Psychiatr Pol 2016; 50 (05) 1039-1052
- 27 Cumming TB, Churilov L, Linden T, Bernhardt J. Montreal Cognitive Assessment and Mini-Mental State Examination are both valid cognitive tools in stroke. Acta Neurol Scand 2013; 128 (02) 122-129
- 28 Lestari S, Mistivani I, Rumende CM, Kusumaningsih W. Comparison between mini mental state examination (MMSE) and Montreal cognitive assessment Indonesian version (MoCA-Ina) as an early detection of cognitive impairments in post-stroke patients. J Phys Conf Ser 2017; 884: 012153
- 29 Trzepacz PT, Hochstetler H, Wang S, Walker B, Saykin AJ. Alzheimer's Disease Neuroimaging Initiative. Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults. BMC Geriatr 2015; 15: 107
- 30 Hampshire A, Trender W, Chamberlain SR, Jolly AE, Grant JE, Patrick F, Mazibuko N, Williams SC, Barnby JM, Hellyer P, Mehta MA. et al. Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine 2021; 39: 101044
- 31 Woo MS, Malsy J, Pöttgen J. et al. Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Commun 2020; 2 (02) a205
- 32 Beaud V, Crottaz-Herbette S, Dunet V. et al. Pattern of cognitive deficits in severe COVID-19. J Neurol Neurosurg Psychiatry 2021; 92 (05) 567-568
- 33 Beaud V, Crottaz-Herbette S, Dunet V. et al. Pattern of cognitive deficits in severe COVID-19. J Neurol Neurosurg Psychiatry 2021; 92 (05) 567-568
- 34 Sahoo S, Mehra A, Dua D. et al. Psychological experience of patients admitted with SARS-CoV-2 infection. Asian J Psychiatr 2020; 54: 102355
- 35 Zandifar A, Badrfam R, Yazdani S. et al. Prevalence and severity of depression, anxiety, stress and perceived stress in hospitalized patients with COVID-19. J Diabetes Metab Disord 2020; 19 (02) 1-8
- 36 Dorman-Ilan S, Hertz-Palmor N, Brand-Gothelf A. et al. Anxiety and depression symptoms in COVID-19 isolated patients and in their relatives. Front Psychiatry 2020; 11: 581598
- 37 Mazza MG, De Lorenzo R, Conte C. et al; COVID-19 BioB Outpatient Clinic Study group. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun 2020; 89: 594-600